These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23616698)

  • 21. Eszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agent.
    Brielmaier BD
    Proc (Bayl Univ Med Cent); 2006 Jan; 19(1):54-9. PubMed ID: 16424933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of chronic insomnia in elderly persons.
    Bain KT
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):168-92. PubMed ID: 16860264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N; Hazra A; Das T
    Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance.
    Bogan RK
    Postgrad Med; 2008 Sep; 120(3):161-71. PubMed ID: 18824834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.
    Morin CM; Vallières A; Guay B; Ivers H; Savard J; Mérette C; Bastien C; Baillargeon L
    JAMA; 2009 May; 301(19):2005-15. PubMed ID: 19454639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone.
    Drover DR
    Clin Pharmacokinet; 2004; 43(4):227-38. PubMed ID: 15005637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
    Huang YS; Hsu SC; Liu SI; Chen CK
    Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
    Roth T; Mayleben D; Corser BC; Singh NN
    Hum Psychopharmacol; 2008 Jan; 23(1):13-20. PubMed ID: 17907263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of insomnia.
    Kirkwood CK
    J Am Pharm Assoc (Wash); 1999; 39(5):688-96; quiz 713-4. PubMed ID: 10533351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.
    Lieberman JA
    Prim Care Companion J Clin Psychiatry; 2007; 9(1):25-31. PubMed ID: 17599165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
    Dündar Y; Boland A; Strobl J; Dodd S; Haycox A; Bagust A; Bogg J; Dickson R; Walley T
    Health Technol Assess; 2004 Jun; 8(24):iii-x, 1-125. PubMed ID: 15193209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
    Wilt TJ; MacDonald R; Brasure M; Olson CM; Carlyle M; Fuchs E; Khawaja IS; Diem S; Koffel E; Ouellette J; Butler M; Kane RL
    Ann Intern Med; 2016 Jul; 165(2):103-12. PubMed ID: 27136278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
    Staner C; Joly F; Jacquot N; Vlasova ID; Nehlin M; Lundqvist T; Edenius C; Staner L
    Curr Med Res Opin; 2010 Jun; 26(6):1423-31. PubMed ID: 20397964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual zolpidem tartrate lozenge for the treatment of insomnia.
    Lankford A
    Expert Rev Clin Pharmacol; 2009 Jul; 2(4):333-7. PubMed ID: 22112177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
    Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T
    Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.